Alkermes Plc (ALKS)

31.76 +0.12 (+0.40%) USD  |  NASDAQ  |  Jan 20, 16:00
31.76 0.00 (0.00%) After-Hours: 20:00
More

Alkermes Accounts Receivable (Quarterly): 355.11M for Sept. 30, 2025

Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accounts Receivable Definition

View Accounts Receivable Definition
Start Trial

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc 42.44M
CorMedix, Inc. 158.57M
Amicus Therapeutics, Inc. 113.84M
Jazz Pharmaceuticals Plc 764.36M
Amarin Corp. Plc 127.31M